Era of metabolic dysfunction-associated steatotic liver disease and impact on the liver donor pool

doi:10.3748/wjg.v31.i37.110164

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 37

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2043)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

HTML

451

Figures (1-1)

Tables (1-2)

Sum=674

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

551

Download

362

Sum=913

Publishing Process of This Article

Item

Count

Browse

128

Download

190

Sum=318

Oct 7, 2025 (publication date) through May 9, 2026

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Oct 7, 2025; 31(37): 110164
Published online Oct 7, 2025. doi: 10.3748/wjg.v31.i37.110164

Era of metabolic dysfunction-associated steatotic liver disease and impact on the liver donor pool

Juanita Pérez-Escobar, Aline Huerta-Álvarez, Graciela Elia Castro-Narro, María Isabel Astudillo-Delgado, Paulina Carpinteyro-Espin

Juanita Pérez-Escobar, Paulina Carpinteyro-Espin, Department of Transplantation, Hospital Juárez de México, Mexico City 07760, Mexico

Aline Huerta-Álvarez, Department of Nutrition, Hospital Juárez de México, Mexico City 07760, Mexico

Graciela Elia Castro-Narro, Hepatology and Transplant Unit, Hospital Médica Sur, Mexico City 14050, Mexico

Graciela Elia Castro-Narro, Department of Gastroenterology, Hepatology and Transplant, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City 14080, Mexico

María Isabel Astudillo-Delgado, Department of Gastroenterology, Hospital Juárez de México, Mexico City 07760, Mexico

Author contributions: Pérez-Escobar J, Huerta-Álvarez A, Castro-Narro GE, and Carpinteyro-Espin P conceptualized the study; Pérez-Escobar J, Huerta-Álvarez A, and Carpinteyro-Espin P revised the subsequent versions; Pérez-Escobar J and Carpinteyro-Espin P generated the figures and tables; all authors performed the investigation, wrote the first draft, and agreed to the published version of the manuscript.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Corresponding author: Paulina Carpinteyro-Espin, MD, Professor, Researcher, Department of Transplantation, Hospital Juárez de México, Avenue Instituto Politécnico Nacional 5160, Mexico City 07760, Mexico. paucarpi@gmail.com

Received: June 3, 2025
Revised: July 7, 2025
Accepted: August 29, 2025
Published online: October 7, 2025
Processing time: 117 Days and 21.2 Hours

Core Tip

Core Tip: Metabolic dysfunction-associated steatotic liver disease has been associated with a decline in the quality of available donor organs. Evaluation of liver graft steatosis is crucial for optimizing the donor pool. To maximize transplant success, decision-making algorithms need to be established, taking into account the degree of steatosis, donor characteristics, ischemia time, and recipient variables. New technologies and artificial intelligence represent future valuable tools.